Zevra Therapeutics Appoints Justin Renz As CFO
(RTTNews) - Zevra Therapeutics, Inc. (ZVRA) announced Thursday the appointment of Justin Renz as Chief Financial Officer, effective March 9, 2026.
Renz brings more than 25 years of financial leadership experience in the biopharmaceutical industry, including extensive expertise in capital markets, strategic transactions, and commercial-stage operations.
Renz most recently served as Chief Financial & Operations Officer at Ardelyx. Previously, he was President and Chief Financial Officer of Correvio Pharma, a global specialty pharmaceutical company.
Renz also served as Executive Vice President, Chief Financial Officer and Treasurer at Karyopharm Pharmaceuticals and as Executive Vice President and Chief Financial Officer at Zalicus Inc.
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.